Medication info

Nutriflex Lipid Peri Injection

Prescription medicationIntravenous injection
Ingredient · strength
Zinc Acetate Hydrate›5.3mg / 400mLMonobasic Sodium Phosphate Dihydrate›936mg / 400mLGlucose Monohydrate›70.4g / 400mLTriglycerides Medium-Chain›20g / 200mLSoybean Oil›20g / 200mLPhenylalanine›2.808g / 400mLMethionine›1.568g / 400mLL-Leucine›2.504g / 400mLIsoleucine›1.872g / 400mLL-Lysine Hydrochloride›2.272g / 400mLThreonine›1.456g / 400mLTryptophan›0.456g / 400mLValine›2.08g / 400mLArginine›2.16g / 400mLL-Histidine Hydrochloride Monohydrate›1.352g / 400mLAlanine›3.88g / 400mLAspartic Acid›1.2g / 400mLGlutamic Acid›2.8g / 400mLGlycine›1.32g / 400mLProline›2.72g / 400mLSerine›2.4g / 400mLSodium Hydroxide›0.64g / 400mLSodium Chloride›0.8648g / 400mLSodium Acetate Hydrate›0.4352g / 400mLPotassium Acetate›2.3544g / 400mLMagnesium Acetate Tetrahydrate›0.5152g / 400mLCalcium Chloride Hydrate›0.3528g / 400mL
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
An aqueous emulsion, consisting of a colorless and transparent bag made of polyamide and polypropylene material, divided into three compartments: two at the top and one at the bottom.
Packaging
Bag - 1250 milliliters / bag, Bag - 1875 milliliters / bag
Approval status
Active

MFDS item code 200511364 · Approved 2005.07.15 · Insurance code 667400050,667400580

Summary

Main use
Correction of deficiencies in nutrients (amino acids and calories), fluids, and electrolytes
Who receives it
Adults
Adult administration
Administer by peripheral intravenous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes~1 hour of infusion until the appropriate dose is reached. Administration over 12~24 hours is recommended. Do not administer for more than 7 days. Do not exceed a maximum infusion rate of 2.5mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.16 g/kg/hour, and fat 0.1g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.28g, glucose 2.56g, and fat 1.6g per kg of body weight)

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Correction of deficiencies in nutrients (amino acids and calories), fluids, and electrolytes

View approved original text

This medication is used to improve the nutritional status of patients who cannot take in nutrients orally or via the gastrointestinal tract by supplementing water, electrolytes, amino acids, and calories. It mainly helps to provide nutrition intravenously in situations where oral intake is impossible or insufficient, or is contraindicated. This helps to prevent and treat nutritional deficiencies in patients.

How it is given

Adult administration

Administer by peripheral intravenous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes~1 hour of infusion until the appropriate dose is reached. Administration over 12~24 hours is recommended. Do not administer for more than 7 days. Do not exceed a maximum infusion rate of 2.5mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.16 g/kg/hour, and fat 0.1g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.28g, glucose 2.56g, and fat 1.6g per kg of body weight)

Precautions

This medication must be used strictly according to a doctor's instructions. If any allergic reactions such as fever, tremors, rashes, or difficulty breathing occur during use, administration should be stopped immediately. When used together with the antibiotic Ceftriaxone, precipitates may form in the bloodstream, so they should not be administered simultaneously using the same infusion device. Particularly in premature infants or low-birth-weight infants, lipid metabolism may be difficult, posing risks, so caution is advised. Should not be administered to premature infants, neonates, patients allergic to eggs or soybean oil, or those with severe kidney or liver disease. Patients with renal failure, pancreatitis, liver dysfunction, or heart or lung diseases should be administered cautiously, and blood lipid levels should be monitored regularly. Overdosage or rapid administration can cause side effects such as fever, tremors, headache, vomiting, and difficulty breathing, necessitating caution. Long-term administration may cause liver dysfunction or blood-related abnormalities, necessitating regular monitoring. Prior to administration, improvements in fluid and electrolyte imbalance, metabolic disorders should be made, and blood glucose and lipid levels monitored frequently. If an anaphylactic reaction is suspected, administration should be stopped immediately and appropriate measures taken. This medication may have stability issues when mixed with other medications, so consultation with a professional regarding concomitant medications is imperative. If pregnant or breastfeeding, as the safety of this medication has not been established, benefits and risks should be carefully considered before administration. Post-administration, since it may affect test results, blood tests are preferably conducted 5-6 hours after administration. Severe symptoms such as metabolic acidosis, electrolyte imbalance, pulmonary edema, or hyperglycemia can occur with overdosage, requiring immediate consultation with healthcare professionals. Do not use if the package is damaged or the solution appears cloudy or discolored, and administer promptly after opening. Store in a sealed container to protect from air and light, preferably at a cool place between 15 to 25°C. Do not freeze.

Side effects

  • Fever
  • sweating
  • tremors
  • headache
  • vomiting
  • shortness of breath
  • increased liver function test values
  • hepatomegaly
  • jaundice
  • thrombophlebitis
Show 31 more
  • hyperlipidemia
  • fever
  • fat deposition
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • abnormal blood coagulation
  • coma
  • flushing
  • chills
  • loss of appetite
  • nausea
  • respiratory distress
  • pain in the back
  • bones
  • chest
  • and waist
  • increased blood pressure
  • decreased blood pressure
  • hypersensitivity symptoms
  • skin erythema
  • cyanosis
  • localized fat accumulation
  • pathological liver function abnormality
  • abnormal blood symptoms
  • hyperlipidemia
  • abdominal pain
  • fatigue
  • phlebitis
  • bleeding

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air or light, preferably at a cool place between 15 to 25 degrees and should not be frozen.

Appearance and packaging

Appearance

An aqueous emulsion, consisting of a colorless and transparent bag made of polyamide and polypropylene material, divided into three compartments: two at the top and one at the bottom.

Package unit

Bag - 1250 milliliters / bag, Bag - 1875 milliliters / bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.